免疫调节合成葡萄糖集群分子 防止黑色素瘤生长 活体
Meija Honkanen1,2, Elli Narvi1, Veera K Ojala1,2,3
1Institute of Biomedicine and MediCity Research Laboratory, University of Turku, Tykistökatu 6A, Turku, Finland.
Chembiochem : a European journal of chemical biology
|June 12, 2024
概括
三胺 (TADM) 显示出作为抗癌疗法的潜力,有效抑制黑色素瘤瘤的生长. 这种合成的葡萄糖集群激活了免疫反应,为癌症治疗提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 三甲基曼 (TADM) 是一种合成的葡萄糖集群,可以独立于曼受体激活巨细胞.
- 已知TADM可诱导Th1型免疫反应,并在过敏炎症模型中抑制Th2型细胞因子.
- 免疫检查点抑制剂,如抗PD-1和抗CTLA-4,已经在向转移性黑色素瘤方面取得了成功.
研究的目的:
- 在黑色素瘤模型中调查TADM在促进抗瘤反应方面的潜力.
- 为了比较TADM与已知免疫检查点抑制剂的疗效.
主要方法:
- 使用了一种突变性老鼠黑色素瘤模型 (B16).
- 评估了瘤生长抑制的结果.
- 使用TUNEL染色量化测量了亡细胞的数量.
- 分析了中的干扰素- (IFN-γ) 表达和免疫细胞群 (单细胞,中性粒细胞).
主要成果:
- TADM抑制了B16黑色素瘤瘤的生长,与抗PD-1抗体相比.
- 治疗TADM导致瘤内亡细胞增加.
- 在TADM治疗小鼠的脏中观察到IFN-γ表达的增加和Ly6C低单细胞和中性粒细胞的升高水平.
- 在TADM治疗组和对照组之间,没有发现瘤透免疫细胞的显著差异.
结论:
- 作为单一疗法,TADM在抑制黑色素瘤瘤生长方面显示出有效性.
- TADM可能通过激活M1巨细胞,N1中性粒细胞,CD8+ T细胞和Th1 T细胞来促进抗瘤免疫反应.
- TADM将瘤微环境从2型转移到1型免疫反应.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K